drugset / Trial / NCT04706559

Efficacy of Oral Supplementation of Probiotics in Children With Atopic Dermatitis

NCT04706559

RandomizedParallel-groupSingle-blindTreatment

Summary

Various clinical studies have evaluated the role of probiotics in children with atopic dermatitis, with some studies showing improvement in clinical outcome after supplementation of probiotics and others showing no additional benefit. This study is to provide clinical evidence of effect of a mixture of probiotics in Atopic Dermatitis (AD) patients based on improvement in SCORAD (SCORing Atopic Dermatitis) index.

Timeline

Start
2021-01-03
Primary completion
2021-09-30
Completion
2021-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Bifidobacterium longum Other / unclassified Oral
Subject Lactobacillus acidophilus Other / unclassified Oral
Subject Lactobacillus rhamnosus Other / unclassified Oral
Subject Saccharomyces boulardii Other / unclassified Oral
Background Cetirizine Other / unclassified 0.3 mg/kg Oral
Background Fluticasone Other / unclassified 0.05 % Topical
Background Tacrolimus Small molecule 0.1 % Topical

Indications